Upper Street Marketing Inc (UPPR): https://www.otcmarkets.com/stock/UPPR/ne...

Play Episode

6min

Proactive - Interviews for investors

Polarean Imaging chief business officer on potential of Xenon MRI pharma trials

Polarean Imaging PLC chief business officer Alex Dusek talked with Proactive's Stephen Gunnion about the company’s latest expansion into pharmaceutical-sponsored trials. This new initiative involves a multinational trial utilising Polarean’s Xenon MRI technology to assist drug development for lung diseases. Dusek explained that traditional lung function tests, such as spirometry, are crude and highly variable, making trials costly and time-consuming. Xenon MRI offers a more sensitive measurement, reducing variability and allowing drug companies to conduct trials with significantly fewer patients. "If you're designing a trial, let's say it's 25 to 50 patients with Xenon, that would take you 250 to 500 patients with the more traditional measures," he noted. Polarean is providing pharmaceutical companies with imaging biomarkers and harmonised data analysis, streamlining drug development. The company is also establishing a network of clinical sites equipped with Xenon MRI, creating an ecosystem that benefits sponsors, trial sites, and Polarean itself. Dusek highlighted Polarean’s partnership with VIDA Diagnostics, a well-known name in lung drug development, to further enhance the impact of this initiative. For more insights into Polarean Imaging’s latest developments, visit Proactive’s YouTube channel. Don’t forget to like, subscribe, and turn on notifications for future updates. #PolareanImaging #XenonMRI #LungDisease #DrugDevelopment #ClinicalTrials #PharmaResearch #MedicalImaging #Biotech #HealthcareInnovation #Investing

Proactive - Interviews for investors

4GLOBAL CEO on successful North America pivot and growth plans

4GLOBAL PLC CEO Eloy Mazon talked with Proactive's Stephen Gunnion about the company’s strategic growth, focusing on its expansion into the North American market, following the release of a trading update for the year to end-March 2025. Mazon emphasised that 4GLOBAL is not focused on short-term gains but on building a high-quality, scalable business. He explained that breaking into North America—a challenging but lucrative market—has been a key transition, and the company has made strong progress. Revenue in the region grew by 145%, reaching £1.6 million by February. The company has also shifted its revenue model, increasing repeatable, high-margin contracts from 60% to 81% of total revenue. Mazon highlighted that this shift enhances long-term growth, revenue predictability, and business resilience. Meanwhile, 4GLOBAL has reduced its focus on lower-margin operations in the Middle East, with revenue there dropping from £2.5 million to £400,000. In the UK and Europe, revenue remains steady at £3.1 million, with strong potential for future growth. Mazon stressed that 4GLOBAL has now laid the groundwork for scalable expansion and is positioned for sustainable long-term success. For more exclusive interviews and insights, subscribe to Proactive's YouTube channel, hit the like button, and turn on notifications for updates. #4GLOBAL #Investment #StockMarket #BusinessGrowth #NorthAmerica #MarketExpansion #CEOInterview #TechStocks #InvestorNews #ProactiveInvestors

Proactive - Interviews for investors

AuKing Mining’s Orion deal: near-term gold production

AuKing Mining Ltd managing director Paul Williams talked with Kerry Stevenson at Proactive about the company's recent agreement with Orion Resources, focusing on gold assets in the Cloncurry region of Queensland. Williams highlighted that AuKing initially acquired a 15% stake in Orion Resources and has now secured approval to increase its ownership to 50% by investing $5 million by June 30, 2027. The acquisition aims to leverage existing infrastructure and near-term production opportunities, with operations potentially commencing within the next 6 to 12 months. "We’re incredibly pleased to be involved in this project," Williams stated. He noted that the deal consolidates key gold assets under one corporate entity for the first time, eliminating previous ownership complexities. Additionally, AuKing recently engaged with the owner of the historic Tick Hill gold mine, which could present another avenue for near-term gold production. The Cloncurry project includes a permitted processing plant at Lorena and several historical mining leases, which, according to Williams, provide a strong foundation for development. The company has also strengthened its leadership team, with key appointments including mining engineer Mark Fisher, geologist Dr. Kylie Prendergast, and finance executive Nick Harding. With gold prices remaining strong, AuKing sees significant potential in these assets and is focused on delivering shareholder value through strategic acquisitions and operational development. For more updates on AuKing Mining and other investment insights, subscribe to Proactive's YouTube channel, give the video a like, and turn on notifications for future updates. #AuKingMining #GoldMining #ASXStocks #MiningInvesting #OrionResources #Cloncurry #GoldProduction #MiningNews #InvestingInGold #TickHillGold #QueenslandMining #MiningUpdates

Proactive - Interviews for investors

Leading Edge Materials to reapply for strategic project status as Norra Kärr development advances

Leading Edge Materials CEO Kurt Budge joined Steve Darling from Proactive provided an update on the company’s Norra Kärr Heavy Rare Earth Elements Project, including a decision on its application for Strategic Project status under the EU Critical Raw Materials Act. While Norra Kärr was not included in the EU’s first list of Strategic Projects, the company remains committed to the initiative and will reapply once the next call for applications is announced. Despite this outcome, Leading Edge Materials has continued to make significant progress at Norra Kärr. Since submitting its application in August 2024, the company has reached a key milestone by submitting a new application for an Exploitation Concession—a 25-year mining lease—and remains focused on exploring innovative pathways for early and sustainable production. Budge also shared updates on the company’s Rapid Development Plan, which is designed to accelerate the extraction process and shorten the timeline to production of heavy rare earth element (HREE) concentrate and nepheline syenite. A key aspect of this strategy is a phased development approach, starting with a small-scale operation to enable early deposit access, generate initial revenue from nepheline syenite sales, and stockpile HREE concentrate for future processing. This approach is intended to minimize both financial risk and environmental impact while establishing a strong foundation for long-term operations. Budge also discussed ongoing testwork on nepheline syenite and aegirine, which is focused on mineralogy, chemical composition, and leachate chemistry. These findings will be crucial in assessing market opportunities, including potential demand and pricing scenarios. The company is actively exploring higher-value markets, such as functional filler products, where prices have ranged between US$100 and US$500 per tonne. Given that nepheline syenite contributed 11% of total revenue in the 2021 Preliminary Economic Assessment (PEA), the compa

Followers	207
Posts	14239
Boards Moderated	15
Alias Born	11/19/2017

Volume:	-
Day Range:
Bid:	0.000001
Ask:	0.000001
Last Trade Time:
Total Trades:

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

UPPR Detailed Quote

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Go Ad-Free